Takeda Signs a Multi-Year Research Collaboration with Evotec to Expedite Research Program Across its Core Therapeutic Areas
Shots:
- The companies allied to support Takeda’s research stage gene therapy discovery programs across its core therapeutic areas i.e. oncology- rare diseases- neuroscience and gastroenterology
- The collaboration leverages s Evotec’s gene therapy capabilities along with its drug discovery platform to support Takeda’s programs
- The partnership will facilitate Takeda’s delivery of transformative therapies for patients- especially with rare diseases
Click here to read full press release/ article
Ref: Evotec | Image:Takeda
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com